NCT00061854View on ClinicalTrials.gov

Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Lung Cancer
Interventions
DRUG

soblidotin

Trial Locations (3)

10021

Memorial Sloan-Kettering Cancer Center, New York

06708

Medical Oncology and Hematology, P.C., Waterbury

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY